# Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

> **NCT00247988** · PHASE2 · TERMINATED · sponsor: **University of Saskatchewan** · enrollment: 38 (—)

## Conditions studied

- Platinum Sensitive Relapsed Ovarian Cancer

## Interventions

- **DRUG:** Weekly Taxotere with weekly carboplatin

## Key facts

- **NCT ID:** NCT00247988
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 38 (—)
- **Why stopped:** Regulatory issues(trial temporarily suspended December 28, 2005. Permanently suspended January 19, 2007. Institutional Reveiw Board informed April 18, 2007
- **Last updated:** 2007-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247988, "Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00247988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*